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doi:10.1016/j.ejvs.2009.07.015Abstract Objective: This study aims to compare venous clinical severity scores in patients
with healed venous ulcers due to varicose veins of the lower limbs (the clinical, etiologic,
anatomic, and pathophysiologic data (CEAP) classification: C5 EpAsPr) treated by saphenous
stripping and phlebectomy or by ultrasound-guided foam sclerotherapy.
Method: Sixty patients were included: 29 underwent saphenous stripping and phlebectomy for
varices in saphenous tributaries and 27 were treated by ultrasound-guided foam sclerotherapy;
four cases were lost to follow-up. The main outcome measure was venous clinical severity
scores (pain, oedema, inflammation, hyperpigmentation and lipodermatosclerosis). An ultra-
sound examination was carried out prior to treatment and 30, 60 and 180 days after the proce-
dure to assess the relative efficacy of the methods in obliterating the saphenous trunk.
Results: The mean venous clinical severity scores measured before and after 180 days were as
follows: Surgery group e pain: before 1.97 standard deviation (SD) 0.19, 180 days 0.72 SD 0.53;
oedema: before 1.66 SD 0.48, 180 days 0.55 SD 0.63; inflammation: before 1.55 SD 0.63, 180
days 0.72 SD 0.45. Foam sclerotherapy group e pain: before 1.81 SD 0.40, 180 days 0.56 SD
0.51; oedema: before 1.70 SD 0.47, 180 days 0.48 SD 0.64; inflammation: before 1.67 SD
0.68, after 0.89 SD 0.32. All scores showed statistically significant reductions in both patient
groups. The saphenous vein had been obliterated, 180 days after treatment, in 78% of the
surgery group, compared with 90% in the foam sclerotherapy group.
Conclusions: Ultrasound-guided foam sclerotherapy is a safe and effective option for patients
with chronic venous disorders.
Crown Copyright ª 2009 Published by Elsevier Ltd on behalf of European Society for Vascular
Surgery. All rights reserved.o, Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, SP, Brazil.
il.com (M. Figueiredo).
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Table 1 Volumes and concentrations of polidocanol in
each segment treated.
Vein treated Foam volume
per session (ml)
Polidocanol
concentration (%)
Great saphenous vein 8e10 3
Small saphenous vein 5 1 or 3
Accessory vein 5 1
Perforating vein 1e2 1
Results of Surgical Treatment Compared with Ultrasound-Guided Foam Sclerotherapy 759A new treatment for primary varicose veins should be
minimally invasive and capable of being used on primary
and recurrent varicose veins so that it can be repeated as
required. There should be few significant complications and
the treatment should have good efficacy in abolishing
venous reflux in saphenous trunks, perforating veins and
varices. Such a treatment should restore normal venous
function and cure the clinical features of venous hyper-
tension. The treatment should be accomplished at little
cost and be capable of achieving both functional and
cosmetic improvement with little time away from the
patient’s usual occupation.1 Surgical treatment does not
comply with this definition, since it is relatively invasive
and necessitates time away from work.
Primary varicose veins are commonly treated by saphe-
nous stripping combined with phlebectomy of saphenous
tributaries and ligation of incompetent perforating veins.2
The rate of recurrence of varicose veins after 5 years has
been reported to vary from 20% to 80%.3
The use of duplex ultrasound in the treatment of vari-
cose veins allows alternative strategies to be used.4
Methods such as endovenous laser ablation, radio-
frequency ablation and foam sclerotherapy have been
increasingly used in these patients. Ultrasound-guided foam
sclerotherapy has been considered particularly attractive
because it avoids the need for general anaesthesia, hospital
admission and long recovery times.5
Few studies have been designed to compare conventional
surgery and endovascular methods for the treatment of
varicose veins.6 The present study aimed to compare the
outcome of varicose vein surgery, including saphenous
stripping and phlebectomies, with ultrasound-guided foam
sclerotherapy.Wewere particularly interested in the clinical
outcomes as well as ultrasound assessment results and have
used clinical severity scores as the main outcome measure.
Method
Patients attending the angiology and vascular surgery
outpatient clinic of a public primary health-care unit in the
municipality of Uberlaˆndia, Brazil, between April and August
2006 were screened for inclusion in this study. A total of 60
patients were selected based on clinical history, physical
examination and duplex ultrasound. The following inclusion
criteria were taken into consideration: no previous clinical
treatment of varicose veins; age between 18 and 70 years;
and primary varicose veins classified as C5 EpAsPr (healed
venous ulcers) according to the clinical, etiological,
anatomic and pathophysiologic (CEAP) classification.7
Patients were excluded if they reported a history of
deep vein thrombosis, thrombophilia, allergy to polidoca-
nol, bronchial asthma, post-thrombotic syndrome, severe
systemic disease, immobility or confinement to bed, preg-
nancy, peripheral arterial insufficiency (ankleebrachial
index <0.8), lower limb oedema, diabetic foot (peripheral
neuropathy or ulceration) or presence of a patent foramen
ovale on echocardiography.
All the selected patients were provided with detailed
information related to conventional surgery and ultra-
sound-guided foam sclerotherapy. Patients who agreed to
participate in the study and who gave informed writtenconsent were randomly allocated to one of the treatment
groups, according to the following randomisation process:
a total of 60 slips of paper were deposited in a sealed box;
half the number of the slips were identified as conventional
surgical treatment of varicose veins, and the other half as
ultrasound-guided foam sclerotherapy. For each patient
included in the study, one slip of paper was drawn, and the
corresponding treatment was initiated 48 h later.
The primary outcome measure assessed in this study was
the venous clinical severity scores prior to treatment and
30, 60 and 180 days after the procedure. These scores were
assigned by the authors after clinical examination at each
follow-up appointment. The frequency of treatment
complications and duplex ultrasound findings at 180 days
were recorded as further measures of efficacy and safety.
This study protocol was approved by the Ethics
Committee of the Universidade Federal de Sa˜o Paulo.
Conventional surgery
The surgical approaches employed were saphenofemoral or
saphenopopliteal ligation combined with saphenous strip-
ping and phlebectomy for varicose saphenous tributaries
and ligation of incompetent perforating veins.8 All surgical
treatments were carried out under regional anaesthesia in
one session. The treated limbs were bandaged immediately
following surgery using inelastic bandages (Linfopress,
Famara, Boituva, SP, Brazil). After 2 days, the bandages
were replaced by below-knee graduated elastic compres-
sion stockings (Comfortline, Venosan, Abreu e Lima, Brazil),
with a compression of 30e40 mmHg for 3 months.
Ultrasound-guided foam sclerotherapy
Injections were made with the patients standing; soon after
the injection, patients were placed in Trendelenburg’s
position, and the great or small saphenous vein was identi-
fied on ultrasound imaging 15e20 cm from the saphenofe-
moral or saphenopopliteal junction. Injections of foamwere
made into the saphenous trunk using a 20-gauge 1.88"
needle. The accessory veins were cannulated using 25-gauge
butterfly needles, and the incompetent perforating veins
were injected using 22-gauge 1.25" needles. Tessari’s
method was used to produce foam.9 The foam was made
from polidocanol (Aethoxysklerol, Kreussler Pharma,
Wiesbaden, Germany) and room air at a 1:4 ratio. Volumes
and concentrations are shown in Table 1.
Foam was injected as a bolus and its progress along the
saphenous vein monitored using ultrasound imaging. A
maximum of 10 ml of foam was injected per session;
760 M. Figueiredo et al.sessions were repeated up to 3 times, as required, at 30-
day intervals. Soon after completion of all injections, the
lower limb was elevated, and the foam was observed to
almost reach the saphenofemoral or saphenopopliteal
junction. In cases where the foam was identified in deep
veins, patients were asked to perform ankle dorsiflexions to
promote clearance of foam from these veins. Manual
compression of the saphenofemoral junction (SFJ) or short
saphenous vein (SSV) was performed using the ultrasound
transducer for 10e15 min.
After 15 min of compression of the SFJ or SSV, the limb
was bandaged using a 12 cm-wide inelastic bandage (Lin-
fopress, Famara, Boituva, SP, Brazil) for 3e5 days. Subse-
quently, 30e40 mmHg below-knee elastic stockings
(Comfortline, Venosan, Abreu e Lima, Brazil) were used for
3 months.
Treatment assessment
Clinical assessment of the two treatment approaches was
based on venous clinical severity scores, taking into
consideration the presence of pain, oedema, inflammation,
hyperpigmentation and lipodermatosclerosis10 prior to the
procedure (first assessment) and 30, 60 and 180 days after
the treatment. Duplex ultrasound was also performed at
180 days to assess treatment effectiveness.
An assessment was carried out 8 2 days after the
procedure (data not shown), aiming to detect deep vein
thrombosis11 in the following veins: femoral, popliteal,
posterior and anterior tibial, fibular, soleal, lateral and
gastrocnemius. Two post-treatment assessments were
carried out, approximately 30 and 60 days after the
procedure, to assess the need for a new foam injection
session in the foam sclerotherapy group and the presence
of residual varicose veins in the conventional surgery group.
Finally, 6 months or 180 days after surgery or after the
last foam sclerotherapy session, a new evaluation was
carried out to assess the effectiveness of the procedures. In
the surgery group, failure was defined as presence of reflux
or residual varicose veins in any of the segments assessed.
In the foam sclerotherapy group, success was assigned to
one of the four grades12: (1) total occlusion; (2) partial
recanalisation without reflux; (3) partial recanalisation
with reflux; and (4) total recanalisation (Fig. 1). The
procedure was considered to be successful in cases pre-
senting total occlusion or partial recanalisation without
reflux; the two remaining categories were considered to
reflect treatment failure.Figure 1 Schematic drawing of ultrasound criteria. (A) Total o
recanalisation with reflux; (D) Total recanalisation.Statistical analysis
The non-parametric ManneWhitney test was used for
significance testing to compare between group differences
before and after treatment (at 180 days) for each venous
clinical severity score (pain, oedema, inflammation,
pigmentation and lipodermatosclerosis). Significance was
considered to have been reached when p< 0.05.
Results
Of the 60 patients selected, 29 were submitted to
conventional surgery (52%) and 27 to ultrasound-guided
foam sclerotherapy (48%). Three patients were lost to
follow-up in the foam sclerotherapy group and one in the
surgery group. The mean age of patients was 49 years
(range: 29e72 years) in the surgery group and 53 years
(range: 25e76 years) in the foam sclerotherapy group.
Women formed the majority in both the groups: 79% of the
surgery and 85% of the sclerotherapy group.
A total of 56 foam sclerotherapy sessions were carried
out as follows: three patients underwent one session, 19
underwent two sessions and five patients were treated
during three sclerotherapy sessions. The average number of
sessions per patient was 2.1.
The venous clinical severity scores obtained before and
after treatment are shown in Table 2. Comparisons
between the surgery and sclerotherapy groups revealed
improvements, with a statistical significance for pain,
oedema and inflammation (p< 0.005).
Duplex ultrasound, carried out 180 days after the
treatment, showed that ultrasound-guided foam scle-
rotherapy was successful in 78% of the patients (21 of the 27
patients treated), whereas conventional surgery had
a success rate of 90% (26 of the 29 patients treated), with
a non-significant difference between the two methods in
terms of effectiveness.
No serious adverse events were associated with any of
the treatments employed. The most frequent complications
recorded are shown in Table 3.
Discussion
In many countries, varicose vein surgery remains the
most common treatment, and saphenous vein stripping
operations the method most commonly used.13 The
potential complications and long-term outcome ofcclusion; (B) Partial recanalisation without reflux; (C) Partial
Table 2 Mean scores obtained prior to treatment and 30, 60 and 180 days after the procedure, according to treatment.
Group/score Pre-treatment mean (SD) 30 days mean (SD) 60 days mean (SD) 180 days mean (SD)
Surgery
Pain 1.97 (0.19) 0.93 (0.53) 0.79 (0.49) 0.72 (0.53)
Oedema 1.66 (0.48) 0.69 (0.60) 0.59 (0.63) 0.55 (0.63)
Inflammation 1.55 (0.63) 0.76 (0.44) 0.72 (0.45) 0.72 (0.45)
Ultrasound-guided foam sclerotherapy
Pain 1.81 (0.40) 0.89 (0.51) 0.59 (0.50) 0.56 (0.51)
Oedema 1.70 (0.47) 0.70 (0.54) 0.56 (0.64) 0.48 (0.64)
Inflammation 1.67 (0.68) 0.89 (0.32) 0.89 (0.32) 0.89 (0.32)
SDZ standard deviation.
p< 0.005 for all scores when comparing pre-treatment and 180-day results.
Results of Surgical Treatment Compared with Ultrasound-Guided Foam Sclerotherapy 761varicose vein surgery are well established, so any new
treatment should provide an equivalent or better
outcome than surgery.
New treatment methods should be compared to surgery
in order to assess their credibility and safety. The impor-
tance of randomised clinical trials for clinical decision
making has been widely recognised.14 Our study aimed at
comparing conventional saphenous stripping with a more
recent method, namely ultrasound-guided foam scle-
rotherapy, in a small group of patients with varicose vein
disorders classified as C5 EpAsPr.
A number of reports have been published concerning the
use of clinical scores for comparing the efficacy of different
treatment methods. In 2003, an article15 validated clinical
scores as the best way to assess results of the surgical
treatment of primary varicose veins; the authors observed
a linear relationship between treatment efficacy and the
CEAP classification. Later, in 2006, the same scoring system
was used in the comparison of post-treatment results in
patients submitted to ultrasound-guided foam scle-
rotherapy with those submitted to surgery.16 The authors
found improved clinical scores in both the groups, similarly
to those observed in our study.Table 3 Complications observed in patients submitted to
conventional surgery and ultrasound-guided foam
sclerotherapy.
Group/Complications Patients affected, n (%)
Surgery (nZ 29)
Infection 1 (3)
Haematoma 2 (7)
Lyphedema 1 (3)
Suture dehiscence 11 (38)
Neurologic, objective 1 (3)
Neurologic, subjective 6 (21)
Lymphoedema 2 (7)
Ultrasound-guided foam sclerotherapy (nZ 27)
Respiratory 1 (2)
Local haematoma 3 (5)
Scotomas 1 (2)
Post-foam extravasation 5 (9)
Thrombus with drainage 5 (9)
Thrombus without drainage 15 (27)Duplex ultrasound has been frequently used in the
assessment of foam sclerotherapy.9,17e20 Establishment of
duplex ultrasound criteria to determine treatment efficacy
is therefore extremely important. In our study, foam scle-
rotherapy was considered to be successful when total
occlusion or partial recanalisation without reflux was ach-
ieved,12 a criterion already adopted in other studies.16,21
Some studies have assessed the efficacy of foam scle-
rotherapy for the treatment of primary varicose veins. In
2006, an article comparing surgical treatment and foam
sclerotherapy22 demonstrated that the conventional
method was superior to foam sclerotherapy in terms of
occlusion and elimination of reflux (86% vs. 63%), while
foam sclerotherapy proved to be superior to liquid scle-
rotherapy (90% vs. 76%). Another clinical trial16 showed that
foam sclerotherapy combined with SFJ ligation presented
lower cost, shorter operating time and faster recovery
when compared with surgical treatment.
Our study is original in that it compared 180-day results
of the conventional method (saphenectomy) with ultra-
sound-guided foam sclerotherapy in a homogeneous
sample: all patients had been diagnosed as C5 EpAsPr.
Previously published randomised studies16,22 have included
patients at different disease stages, varying from C2 to C6 in
the CEAP classification, thus making comparison of results
more difficult in view of the various clinical manifestations
that may be present. One of these trials16 compared
surgery and foam sclerotherapy and showed an 89%
saphenous obliteration rate in the surgery group compared
with 78% in the foam sclerotherapy patients; in another
trial,22 saphenous reflux was abolished in 85% of surgery
patients and 84% of foam sclerotherapy patients 12 months
after treatment. The use of a non-homogeneous sample
may lead to false conclusions, because patients with
a milder form of varicose disease cannot be compared in
terms of clinical recovery with those affected more
severely. A recent meta-analysis23 has concluded that data
are still insufficient to prescribe one or the other treatment
as the best option.
Results obtained in our study were similar to those
published in clinical series, with 90% success for the surgical
treatment, compared with 78% for the ultrasound-guided
foam sclerotherapy. The great saphenous vein was the most
commonly treated vessel: 27 in the surgery group and 25 in
the foam sclerotherapy group, with 96% vs. 80% of success,
respectively.
762 M. Figueiredo et al.Compression bandaging and stockings were used after
surgery and after sclerotherapy, in accordance with the
latest European consensus on foam sclerotherapy.24 Before
inclusion in the present study, none of the patients had
been submitted to clinical treatment with compression
stockings; after treatment, elastic stockings were used for
3 months only. Since the use of elastic stockings was
identical in both treatment groups and was discontinued 3
months before the 180-day evaluation, the improvement
observed in our patients probably did not result from
compression only.
In the duplex ultrasound assessment of patients treated
surgically, eight limbs had residual varicose veins at the 6-
month assessment. Ultrasound-guided foam sclerotherapy
usually prevents this problem since it can easily be
repeated should residual varices be found during follow-up.
There is no need for general anaesthesia or hospital
treatment, which greatly facilitates the use of this
treatment.
Complications are inherent to any invasive technique
and may occur following both surgical treatment and
ultrasound-guided foam sclerotherapy. The complications
observed in our patients treated surgically were similar to
those reported in the published literature, but no severe
complication occurred in the two groups. Suture dehis-
cence affected almost half of our patients in the surgery
group, a finding that can be explained by the strictness
adopted in the present analysis for the assessment of
complications, especially those related with the healing of
incisions.
A previous study25 has identified post-sclerotherapy
thrombophlebitis and consequent hyperpigmentation as the
most frequent complication associated with foam scle-
rotherapy. In an earlier publication, 20 cases of chemical
thrombophlebitis were diagnosed, of which 15 required
aspiration drainage21; the remaining five cases improved
spontaneously in 30 days, forming a fibrous cord. Hyper-
pigmentation, however frequent, is of little importance
because patients with thrombophlebitis were already
affected by cutaneous and subcutaneous disorders such as
hyperpigmentation and lipodermatosclerosis.
Regarding the risk of thrombo-embolism, previous
studies26 have shown that the foam reaches the right
ventricle easily, with no significant complication. In our
study, foam was always found in the deep venous system;
however, due to the small amount injected and to the high
flow of the deep venous system, no complication occurred.
In Brazil, an increased interest in ultrasound-guided foam
sclerotherapy can be observed in response to the advantages
offered by this method, since it may be carried out on an
outpatient basis and there is a substantial reduction in time
away from work. These factors have influenced the medical
community as well as patients who now seek minimally
invasive treatment for their varicose veins.
The results obtained with our patients suggest that both
treatments (surgery and ultrasound-guided foam scle-
rotherapy) have similar efficacy in patients with C5 varicose
veins. In the Brazilian public health-care system, patients
have to wait a long time to receive surgical treatment,
whereas ultrasound-guided foam sclerotherapy represents
a treatment option that can be carried out safely in
outpatient clinics and at significantly lower costs.The main limitations of the present study refer to the
small number of patients assessed and the short period of
follow-up. On the other hand, the fact that we were
working with a homogeneous sample (all patients classified
as C5 EpAsPr) allowed discussing the management of this
specific type of patient. Further studies involving homoge-
neous samples should be carried out with the aim of
defining a more accurate classification profile.
Conclusion
Our study in patients with healed venous ulcers suggests
that ultrasound-guided foam sclerotherapy is effective in
obliterating saphenous trunks. The technique has the
advantage of reaching areas that are more difficult to treat
surgically, especially regions of the limb affected by lip-
odermatosclerosis, where incisions tend to heal slowly.
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